Showing 1421-1430 of 6063 results for "".
How do you manage a complex medical referral?
https://practicaldermatology.com/topics/practice-management/how-do-you-manage-a-complex-medical-referral-/18794/Management of complex medical dermatology referrals has evolved, says Joseph Jorizzo, MD, FAAD, Professor; Former & Founding Chair, Dermatology Dept., Wake Forest University and Professor of Dermatology, Weill Cornell Medical College. In this edition of Ask an Expert, he talks to host Adam FriedThe Role of Microneedling in Practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-role-of-microneedling-in-practice/18627/Microneedling is gaining in popularity. Amy Forman Taub, MD discusses how she's using microneedling in combination with other treatments like PDT and RF to enhance efficacy and for faster results. She says the number one reason she uses microneedling is for scars. She also cautions on when not to usOffering Patients a Clean Slate with PicoWay
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/offering-patients-a-clean-slate-with-picoway/18656/Vic Narurkar, MD shares his work with Project New Start and helping high-risk youth with gang-related tattoos get a new start. Through the program, which Syneron-Candela helps to support, physicians volunteer to remove tattoos and help these patients turn their lives around through community serviceClinical Conversations: Discover Dr J Scott Boswell’s Perspective on Redefining PN and AD Through a Neuroimmune Lens
https://practicaldermatology.com/programs/nemluvio-peer-network/clinical-conversations-discover-dr-j-scott-boswells-perspective-on-redefining-pn-and-ad-through-a-neuroimmune-lens/56421/In this Clinical Conversations newsletter, Dr Scott Boswell shares how reframing prurigo nodularis (PN) and atopic dermatitis (AD) as neuroimmune-driven conditions has shaped his clinical philosophy. He shares his 3‑step approach to patient communication, highlights real‑world treatment journeys inTherapeutic Advances and Fighting for Authorizations
https://practicaldermatology.com/programs/practical-dermatology/therapeutic-advances-and-fighting-for-authorizations/35890/Joel L. Cohen, MD, FAAD, and Leon Kircik, MD, FAAD, discuss the latest developments in psoriasis and atopic dermatitis, as well as the challenges involved with fighting for prior authorizations for the best therapies, at Music City SCALE 2025.Pearls from CSF 2022
https://practicaldermatology.com/conferences/cosmetic-surgery-forum-2022/pearls-from-csf-2022/20163/It’s not just the attendees who learned at this year’s Cosmetic Surgery Forum. Meeting founder Joel Schlessinger, MD discusses some of the presentations that were most impactful to him. From presentations about the effectiveness of new technology to discussions about the usefulness of hyaluronidaseDermwireTV Extra: More than Skin Deep
https://practicaldermatology.com/series/dermwire-tv/more-than-skin-deep/20153/Julie Block, President & CEO at the National Eczema Association, discusses the toll that a child's eczema can take on the whole family. Visit understandad.com to learn more and to access the new Blue’s Clues & You! Storybook.DermWireTV: Medicare Cuts; Revision, Alastin, Obagi Acquisitions; CSF Hits Nashville
https://practicaldermatology.com/topics/practice-management/dermwiretv-medicare-cuts-revision-alastin-obagi-acquisitions-csf-hits-nashville/20033/Congress is working to avert a potential pay cut for physicians who treat Medicare patients, and a bipartisan solution has been introduced. Cuts loom as the AMA has released data showing that Medicare claims data exclusive to physician services fell an estimated $13.9 billion or 14 percent below expDERM2020 Content Recap: Linda Stein Gold, MD
https://practicaldermatology.com/conferences/dermatology-education-foundation-derm-2020/derm2020-content-recap-linda-stein-gold-md/19845/DERM2020 Faculty Linda Stein Gold, MD discusses what’s new in acne from her presentation during DERM2020.Dupixent, Juvéderm Vollure XC, Bavencio Approvals
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-dupixent-juv-derm-vollure-xc-bavencio-approvals/18698/The FDA has approved Regeneron's injectable Dupixent (dupilumab) to treat adults with moderate-to-severe eczema. It will be marketed by Regeneron and Sanofi Genzyme in the US. Allergan's Juvéderm Vollure XC has received FDA approval based on a pivotal clinical trial in which 59 percent of subjects s